Fig. 5

IRGP model and drug sensitivity. (A) Drug sensitivity analysis of IRGP model genes. (B) Relationship between riskscores of colorectal cancer cell lines based on the IRGP model and Oxaliplatin IC50. (C) Relationship between riskscores of colorectal cancer cell lines based on the IRGP model and Irinotecan IC50. (D) Relationship between riskscores of colorectal cancer cell lines based on the IRGP model and 5-Fluorouracil IC50. (E) Relationship between riskscores of colorectal cancer cell lines based on the IRGP model and Cisplatin IC50. (F) Relationship between riskscores of colorectal cancer patients and clinical response to drug treatment.